Epistem Announces the Successful Evaluation of New RNA-Amplification Technology

February 19, 2015 Leave a comment 2,735 Views

MANCHESTER, UNITED KINGDOM, Feb 12, 2015 – Epistem Holdings Plc (EHP), the Personalised Medicine and Biotechnology company, announces today the successful evaluation of RNA-Amp(TM) for single cell expression profiling. The results have been published in BMC Genomics (Rothwell et al. ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Epistem

Epistem Announces the Successful Evaluation of New RNA-Amplification Technology

SUsPECT – a pipeline for variant effect prediction based on custom long-read transcriptomes for improved clinical variant annotation

Postdoc position available – immunology and immunotherapy

Advancing personalized medicine one cell at a time

PIE-seq – identifying RNA-binding protein targets by dual RNA-deaminase editing and sequencing

The relevance of single-cell analysis approaches for the characterization of amniotic fluid cells

Space-time scRNA-seq of healing skin wounds

Spatial RNA sequencing reveals where atherosclerotic plaques rupture can lead to preventive treatments